Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Enterprise Value: 2017-2025

Historic Enterprise Value for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $173.1 million.

  • Puma Biotechnology's Enterprise Value rose 510.64% to $173.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$117.1 million, marking a year-over-year increase of 56.89%. This contributed to the annual value of $48.8 million for FY2024, which is 76.09% down from last year.
  • Puma Biotechnology's Enterprise Value amounted to $173.1 million in Q3 2025, which was up 133.15% from $74.2 million recorded in Q2 2025.
  • Puma Biotechnology's Enterprise Value's 5-year high stood at $282.2 million during Q1 2021, with a 5-year trough of $28.3 million in Q3 2024.
  • For the 3-year period, Puma Biotechnology's Enterprise Value averaged around $90.4 million, with its median value being $72.9 million (2023).
  • In the last 5 years, Puma Biotechnology's Enterprise Value plummeted by 86.56% in 2021 and then spiked by 510.64% in 2025.
  • Over the past 5 years, Puma Biotechnology's Enterprise Value (Quarterly) stood at $42.2 million in 2021, then spiked by 165.45% to $112.0 million in 2022, then skyrocketed by 82.09% to $203.9 million in 2023, then plummeted by 76.09% to $48.8 million in 2024, then spiked by 510.64% to $173.1 million in 2025.
  • Its Enterprise Value was $173.1 million in Q3 2025, compared to $74.2 million in Q2 2025 and $53.7 million in Q1 2025.